TFAP2B Gene Char Syndrome Genetic Test
Test Name: TFAP2B Gene Char syndrome Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for TFAP2B Gene Char syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TFAP2B Gene Char syndrome NGS Genetic DNA Test gene TFAP2B
Test Details
The TFAP2B gene is associated with a condition called Char syndrome, also known as patent ductus arteriosus with facial dysmorphology and abnormal auricles. This genetic test uses next-generation sequencing (NGS) technology to analyze the TFAP2B gene for any mutations or variations that may be responsible for the development of Char syndrome.
NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of Char syndrome, NGS can identify specific mutations or variations in the TFAP2B gene that may be causing the symptoms associated with the condition.
The test typically involves obtaining a sample of DNA, usually through a blood sample or cheek swab, from the individual undergoing testing. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the TFAP2B gene.
The results of the test can help confirm a diagnosis of Char syndrome and provide valuable information for genetic counseling and management of the condition. Additionally, NGS technology allows for the detection of other genetic variants that may be associated with the syndrome, providing a more comprehensive understanding of the genetic basis of the disorder.
It is important to note that genetic testing for Char syndrome is typically performed in a clinical setting and should be ordered and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate guidance and support throughout the testing process and help interpret the results in the context of an individual’s specific medical history and symptoms.
| Test Name | TFAP2B Gene Char syndrome Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Dysmorphology |
| Doctor | Pediatrics |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for TFAP2B Gene Char syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TFAP2B Gene Char syndrome NGS Genetic DNA Test gene TFAP2B |
| Test Details |
The TFAP2B gene is associated with a condition called Char syndrome, also known as patent ductus arteriosus with facial dysmorphology and abnormal auricles. This genetic test uses next-generation sequencing (NGS) technology to analyze the TFAP2B gene for any mutations or variations that may be responsible for the development of Char syndrome. NGS is a high-throughput sequencing method that allows for the simultaneous analysis of multiple genes or even the entire genome. In the case of Char syndrome, NGS can identify specific mutations or variations in the TFAP2B gene that may be causing the symptoms associated with the condition. The test typically involves obtaining a sample of DNA, usually through a blood sample or cheek swab, from the individual undergoing testing. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the TFAP2B gene. The results of the test can help confirm a diagnosis of Char syndrome and provide valuable information for genetic counseling and management of the condition. Additionally, NGS technology allows for the detection of other genetic variants that may be associated with the syndrome, providing a more comprehensive understanding of the genetic basis of the disorder. It is important to note that genetic testing for Char syndrome is typically performed in a clinical setting and should be ordered and interpreted by a qualified healthcare professional or genetic counselor. They can provide appropriate guidance and support throughout the testing process and help interpret the results in the context of an individual’s specific medical history and symptoms. |
